Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants
Ward, Brian J., et al. “Phase 1 Trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants.” MedRxiv, Cold Spring Harbor Laboratory Press, Nov. 2020, p. 2020.11.04.20226282. www.medrxiv.org, doi:10.1101/2020.11.04.20226282.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial
Related
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial